Phytomedicine, Год журнала: 2025, Номер unknown, С. 156841 - 156841
Опубликована: Май 1, 2025
Язык: Английский
Phytomedicine, Год журнала: 2025, Номер unknown, С. 156841 - 156841
Опубликована: Май 1, 2025
Язык: Английский
Phytomedicine, Год журнала: 2024, Номер 128, С. 155529 - 155529
Опубликована: Март 11, 2024
Язык: Английский
Процитировано
34Acta Pharmacologica Sinica, Год журнала: 2023, Номер 45(2), С. 248 - 267
Опубликована: Окт. 13, 2023
Язык: Английский
Процитировано
42European Journal of Pharmacology, Год журнала: 2023, Номер 957, С. 175979 - 175979
Опубликована: Авг. 21, 2023
Cerebral ischemia/reperfusion injury (CIRI) seriously threatens human life and health. Scutellarin (Scu) exhibits neuroprotective effects, but little is known about its underlying mechanism. Therefore, we explored protective effect on CIRI the Our results demonstrated that Scu rescued HT22 cells from cytotoxicity induced by oxygen glucose deprivation/reoxygenation (OGD/R). also showed antioxidant activity promoting nuclear factor erythroid 2-related 2 (Nrf2) translocation, upregulating heme oxygenase-1 (HO-1) expression, increasing superoxide dismutase (SOD) activity, inhibiting reactive species (ROS) generation in vitro. Additionally, reduced factor-kappa B (NF-κB) levels of pro-inflammatory factors. Interestingly, these effects were abolished Nrf2 inhibition. Furthermore, infarct volume blood-brain barrier (BBB) permeability, improved sensorimotor functions depressive behaviors, alleviated oxidative stress neuroinflammation rats subjected to middle cerebral artery occlusion/reperfusion (MCAO/R). Mechanistically, Scu-induced accumulation inactivation NF-κB accompanied an enhanced level phosphorylated protein kinase (p-AKT) both vitro vivo. Pharmacologically phosphatidylinositol-3-kinase/protein (PI3K/AKT) pathway blocked translocation NF-κB, as well anti-inflammatory activities. In summary, suggest antioxidant, anti-inflammatory, through activation mediated PI3K/Akt pathway.
Язык: Английский
Процитировано
36Mitochondrion, Год журнала: 2023, Номер 69, С. 71 - 82
Опубликована: Янв. 26, 2023
Blood-brain barrier disruption plays an important role in central nervous system diseases. This review provides information on the of mitochondrial oxidative stress brain microvascular endothelial cells cellular dysfunction, intercellular junctions, transporter abnormal angiogenesis, neurovascular decoupling, and involvement aggravation vascular inflammation illustrates related molecular mechanisms. In addition, recent drug nondrug therapies targeting cerebral cell mitochondria to repair blood–brain are discussed. shows that disorder a key occurrence development damage may be critical various pathological mechanisms damage. These new findings suggest potential strategy for treatment diseases through modulation cells.
Язык: Английский
Процитировано
32Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 179, С. 117340 - 117340
Опубликована: Авг. 27, 2024
Scutellarin (Scu), a flavonoid from herbal Erigeron breviscapus (Vaniot) Hand-Mazz, exerts neuroprotective effects against cerebral ischemia. However, whether the of Scu are related to mitochondrial protection needs further investigation. In this study, we aimed clarify mechanisms HT22 cells injury caused by oxygen-glucose deprivation and reperfusion (OGD/R). Our results proved that significantly reduced overload intracellular reactive oxygen species (cellar ROS) mitochondria (mito-ROS), ameliorating oxidative stress damage. TUNEL positive rate, Caspase-3 activity, Cytochrome c (Cyto-c) expression remarkably decreased following treatment. Meanwhile, could maintain morphology reverse ultrastructure changes. And membrane potential (MMP), consumption rate (OCR), adenosine triphosphate (ATP) production Na
Язык: Английский
Процитировано
11Journal of Ethnopharmacology, Год журнала: 2022, Номер 296, С. 115453 - 115453
Опубликована: Июнь 11, 2022
Язык: Английский
Процитировано
32APOPTOSIS, Год журнала: 2023, Номер 28(5-6), С. 702 - 729
Опубликована: Март 9, 2023
Язык: Английский
Процитировано
23Pharmacology & Therapeutics, Год журнала: 2023, Номер 251, С. 108541 - 108541
Опубликована: Окт. 1, 2023
Язык: Английский
Процитировано
23CNS Neuroscience & Therapeutics, Год журнала: 2023, Номер 29(12), С. 3876 - 3888
Опубликована: Июнь 23, 2023
Abstract Aim We aimed to assess the effects of cerebral glucagon‐like peptide‐1 receptor (GLP‐1R) activation on glymphatic system and whether this effect was therapeutic for traumatic brain injury (TBI). Methods Immunofluorescence employed evaluate function. The blood–brain barrier (BBB) permeability, microvascular basement membrane, tight junction expression were assessed using Evans blue extravasation, immunofluorescence, western blot. Immunohistochemistry performed axonal damage. Neuronal apoptosis evaluated Nissl staining, terminal deoxynucleotidyl transferase‐mediated dUTP nick end labeling (TUNEL) Cognitive function behavioral tests. Results Cerebral GLP‐1R restored transport following TBI, alleviating BBB disruption neuronal apoptosis, thereby improving cognitive TBI. Glymphatic suppression by treatment aquaporin 4 inhibitor TGN‐020 abolished protective agonist against impairment. Conclusion can effectively ameliorate neuropathological changes impairment TBI; underlying mechanism could involve repair damaged
Язык: Английский
Процитировано
20Clinical and Translational Medicine, Год журнала: 2025, Номер 15(2)
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
1